Chromosome 4p16.3 variant modify bladder cancer risk in a Chinese population

Carcinogenesis

Volumn 32, Issue 6, 2011, Pages 872-875

  Wang, Meilin ^a,b,c   Chu, Haiyan ^c   Yan, Fu ^a,b   Qin, Chao ^c   Li, Pu ^c   Yuan, Lin ^c   Yin, Changjun ^d   Xu, Jianfeng ^e   Zhang, Zhengdong ^a,b,c  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Nanjing Medical University   (China)

^c Cancer Center   (China)

^d THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 3; GENOMIC DNA; MESSENGER RNA;

AGED; ARTICLE; ATTRIBUTABLE RISK; BLADDER CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CHINESE; CHROMOSOME 4P; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

EID: 79958202408     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr060     Document Type: Article

References (19)

1. Kakehi,Y. et al. (2010) Bladder CancerWorking Group report. Jpn. J. Clin. Oncol., 40 (suppl. 1), i57-i64.
2. Murta-Nascimento,C. et al. (2007) Epidemiology of urinary bladder cancer: from tumor development to patient's death. World J. Urol., 25, 285-295.
3. Hardy,J. et al. (2009) Genomewide association studies and human disease. N. Engl. J. Med., 360, 1759-1768.
4. Kiemeney,L.A. et al. (2008) Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat. Genet., 40, 1307-1312.
5. Wu,X. et al. (2009) Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Nat. Genet., 41, 991-995.
6. Kiemeney,L.A. et al. (2010) A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer. Nat. Genet., 42, 415-419.
7. Wang,M. et al. (2009) Common genetic variants on 8q24 contribute to susceptibility to bladder cancer in a Chinese population. Carcinogenesis, 30, 991-996.
8. Wang,S. et al. (2010) Genetic variation in PSCA and bladder cancer susceptibility in a Chinese population. Carcinogenesis, 31, 621-624.
9. Wang,M. et al. (2010) A novel XPF -357A>C polymorphism predicts risk and recurrence of bladder cancer. Oncogene, 29, 1920-1928.
10. Kinoshita,K. et al. (2005) Aurora A phosphorylation of TACC3/maskin is required for centrosome-dependent microtubule assembly in mitosis. J. Cell Biol., 70, 1047-1055.
11. Pascreau,G. et al. (2005) Phosphorylation of maskin by Aurora-A participates in the control of sequential protein synthesis during Xenopus laevis oocyte aturation. J. Biol. Chem., 280, 13415-13423.
12. Peset,I. et al. (2005) Function and regulation of Maskin, a TACC family protein, in microtubule growth during mitosis. J. Cell Biol., 170, 1057-1066.
13. Cappellen,D. et al. (1999) Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas. Nat. Genet., 23, 18-20.
14. Zuiverloon,T.C. et al. (2010) Fibroblast growth factor receptor 3 mutation analysis on voided urine for surveillance of patients with low-grade nonmuscle-nvasive bladder cancer. Clin. Cancer Res., 16, 3011-3018.
15. Burger,M. et al. (2008) Prediction of progression of non-muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a rospective study. Eur. Urol., 54, 835-843.
16. Hernandez,S. et al. (2006) Prospective study of FGFR3 mutations as a prognostic factor in nonmuscle invasive urothelial bladder carcinomas. J. Clin. Oncol., 4, 3664-3671.
17. van Rhijn,B.W. et al. (2003) Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome. J. Clin. Oncol., 21, 1912-1921.
18. Wu,X.R. (2005) Urothelial tumorigenesis: a tale of divergent pathways. Nat. Rev. Cancer, 5, 713-725.
19. Cohen,S.M. et al. (2000) Epidemiology and etiology of premalignant and malignant urothelial changes. Scand. J. Urol. Nephrol. Suppl., 205, 105-115.